¼¼°èÀÇ ºñÀ§°ü ½ÃÀå
Nasogastric Tubes
»óǰÄÚµå : 1775027
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 466 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ºñÀ§°ü ¼¼°è ½ÃÀåÀº 2030³â±îÁö 7¾ï 10¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 5¾ï 4,340¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ºñÀ§°ü ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ 2024-2030³â¿¡ CAGR 4.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 7¾ï 10¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¼ºÀΠȯÀÚ´Â CAGR 4.9%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 3¾ï 9,990¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼Ò¾Æ ȯÀÚ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 3.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1¾ï 4,800¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ºñÀ§°ü ½ÃÀåÀº 2024³â¿¡ 1¾ï 4,800¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2024³âºÎÅÍ 2030³â ºÐ¼® ±â°£ µ¿¾È CAGR 8.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 1¾ï 4,460¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 1.7%¿Í 3.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 2.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºñÀ§°ü ¼¼°è ½ÃÀå µ¿Çâ - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

ºñÀ§°ü ½ÃÀåÀº ÀÇ·á ¹× ¿µ¾ç ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ ¾î¶»°Ô ÁøÈ­Çϰí Àִ°¡?

ºñÀ§°ü(NG Æ©ºê) ½ÃÀåÀº ȯÀÚÀÇ Æí¾ÈÇÔ°ú Ä¡·á È¿À²À» ³ôÀÌ´Â Àç·á, µðÀÚÀÎ, Àû¿ë ±â¼úÀÇ °³¼±À¸·Î Å« ¹ßÀüÀ» °ÅµìÇϰí ÀÖ½À´Ï´Ù. NG Æ©ºê´Â °æÀ念¾ç, ¾à¹°Åõ¿©, À§°¨¾Ð¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖÀ¸¸ç, º´¿ø, Àç°¡ °£È£ ȯ°æ, ÁßȯÀÚ½Ç(ICU)¿¡¼­ Áß¿äÇÑ µµ±¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ Æú¸®¿°È­ºñ´ÒÀ» ±âº»À¸·Î ÇÑ Æ©ºê¸¦ ½Ç¸®ÄÜÀ̳ª Æú¸®¿ì·¹Åº°ú °°Àº º¸´Ù À¯¿¬ÇÏ°í »ýüÀûÇÕ¼ºÀÌ ³ôÀº ¼ÒÀç·Î Á¡Â÷ ´ëüµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸·Èû ¹æÁö ¹× Ç×±Õ ÄÚÆÃµÈ NG Æ©ºêÀÇ °³¹ß·Î °¨¿°°ú ¸·ÈûÀ» ÃÖ¼ÒÈ­ÇÏ¿© ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. ¿¬ÇÏÀå¾Ö, ½Å°æÁúȯ, ¼ÒÈ­±â ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ƯÈ÷ °í·ÉÈ­ »çȸ¿Í ÁßÁõ ȯÀÚ¿¡¼­ ºñÀ§°ü ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀçÅÃÀÇ·á ¼­ºñ½ºÀÇ È®´ë´Â Àå±â °æÀ念¾ç ¼Ö·ç¼ÇÀÇ Çʿ伺¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖÀ¸¸ç, NG Æ©ºê´Â ¸¸¼ºÁúȯ °ü¸®¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.

´Ù¾çÇÑ ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ºñÀ§°ü ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

³úÁ¹Áß, ¾Ï, ½Å°æÁúȯ µî °æÀ念¾çÀ» ÇÊ¿ä·Î ÇÏ´Â ÁúȯÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó NG Æ©ºêÀÇ »ç¿ë·®ÀÌ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. º´¿øÀ̳ª ÀÇ·á ½Ã¼³¿¡¼­´Â ÁßÁõ ȯÀÚÀÇ ´Ü±â ¿µ¾ç °ø±ÞÀ» À§ÇØ Àå±â ¿ä¾ç ½Ã¼³À̳ª Àç°¡ ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â Áö¼ÓÀûÀÎ ¿µ¾ç °ø±ÞÀ» À§ÇØ ÀÌ ±â±¸¸¦ Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. ¿¬ÇÏÀå¾Ö·Î À̾îÁö´Â µÎ°æºÎ¾ÏÀÇ À¯º´·ü Áõ°¡´Â ½ÃÀå È®´ë¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, NG Æ©ºê´Â ÀÀ±Þ ÀÇ·á ¹× ¿Ü»ó Ä¡·á¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, À§ÀåÀÇ °¨¾Ð ¹× ¼·ÃëÇÑ µ¶¼Ò¸¦ ÈíÀÔÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ¹Ì¼÷¾Æ³ª ¼±Ãµ¼º ±âÇüÀ» °¡Áø ¿µ¾ÆµéÀº Ư¼öÇÑ ¿µ¾ç º¸Ãæ ¹æ¹ýÀ» ÇÊ¿ä·Î ÇÏ´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ¼Ò¾Æ ÀÇ·á ¹× ½Å»ý¾Æ ÀÇ·á ºÐ¾ß¿¡¼­µµ NG Æ©ºê¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ö¼ú ÈÄ ¿µ¾ç°ü¸®°¡ ÇÊ¿äÇÑ ¼ö¼úÀÌ Áõ°¡ÇÔ¿¡ µû¶ó, ƯÈ÷ ¼ÒÈ­±â ¼ö¼ú°ú ºñ¸¸ ¼ö¼ú¿¡¼­ NG Æ©ºê ½ÃÀåÀÌ °­È­µÇ°í ÀÖ½À´Ï´Ù.

±â¼ú Çõ½Å°ú ±ÔÁ¦ °³¹ßÀº ¾î¶»°Ô ½ÃÀåÀ» Çü¼ºÇϰí Àִ°¡?

ºñÀ§°ü ¾÷°è¿¡¼­´Â ¾ÈÀü¼º Çâ»ó, ÇÕº´Áõ °¨¼Ò, ȯÀÚ ÆíÀǼº Çâ»óÀ» À§ÇÑ ¸î °¡Áö ±â¼ú Çõ½ÅÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¹æ»ç¼± ºÒÅõ°ú¼º ¹× »ö»óÀ¸·Î ±¸ºÐµÈ ºñÀ§°ü µµÀÔÀ¸·Î ºñÀ§°ü »ç¿ëÀÇ Áß¿äÇÑ ¹®Á¦ÀÎ »ðÀÔ À§Ä¡ È®ÀÎÀÌ °³¼±µÇ¾î ¿À»ðÀÔÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. pH ¹Î°¨µµ Ç¥½Ã±â¿Í ÀüÀÚ±â½Ä À¯Ä¡ È®ÀÎ ½Ã½ºÅÛÀÇ °³¹ß·Î Æ©ºêÀÇ À§Ä¡ °áÁ¤ Á¤È®µµ°¡ ´õ¿í Çâ»óµÇ¾î X-ray È®Àο¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãß°í ¹æ»ç¼± ÇÇÆøÀ» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, Ç×±Õ ÄÚÆÃ°ú ÇÏÀ̵å·Î°Ö º£À̽ºÀÇ NG Æ©ºê´Â ¹ÚÅ׸®¾ÆÀÇ ÄÝ·Î´Ï Çü¼ºÀ» ÁÙÀÌ°í °¨¿°À» ¿¹¹æÇÏ´Â ´É·ÂÀ¸·Î Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. FDA¿Í À¯·´ÀǾàǰû(EMA)°ú °°Àº ±ÔÁ¦ ±â°üÀº NG Æ©ºêÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇØ º¸´Ù ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀ» ½ÃÇàÇϰí ÀÖÀ¸¸ç, Á¦Á¶¾÷ü´Â °íǰÁúÀÇ Ç¥ÁØÈ­µÈ Á¦Ç°¿¡ ´ëÇÑ ÅõÀÚ¸¦ Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã¼³¿¡¼­ °¨¿° °ü¸®¿Í ȯÀÚ ¾ÈÀüÀ» ¿ì¼±½ÃÇÏ´Â °æÇâÀÌ °­È­µÇ°í ÀÖÀ¸¸ç, °í±Þ NG ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä´Â È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºñÀ§°ü ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¼ºÀå ¿äÀÎÀº ¹«¾ùÀΰ¡?

ºñÀ§°ü ½ÃÀåÀÇ ¼ºÀåÀº »ïÅ´ Àå¾Ö ¹× À§Àå Àå¾ÖÀÇ À¯º´·ü Áõ°¡, °æÀ念¾ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Æ©ºê¸¦ »ðÀÔÇÏ´Â ±â¼úÀÇ ¹ßÀü µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â °í·ÉÈ­À̸ç, Àå±â °æÀ念¾çÀ» ÇÊ¿ä·Î ÇÏ´Â ÁúȯÀÇ ¹ß»ý·üÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀçÅÃÀÇ·á ¼­ºñ½ºÀÇ È®´ëµµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, º´¿ø ¹Û¿¡¼­ °æÀ念¾çÀ» ¹Þ´Â ȯÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ ¼¼°è º¸°Ç À§±â¿¡ ´ëÇÑ ´ëÀÀÀ¸·Î ÁßȯÀڽǰú ÁßȯÀÚ½Ç ½Ã¼³ÀÇ È®´ë´Â ÀÀ±Þ ¹× ÁßȯÀÚ Ä¡·á Àå¸é¿¡¼­ NG Æ©ºêÀÇ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½ÀÀû ÀÇ·á ½Ã¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¾ÈÀü¼ºÀ» ³ôÀ̰í, ÇÕº´ÁõÀ» ÁÙÀ̸ç, ȯÀÚ °æÇèÀ» °³¼±Çϰí, »ç¿ëÇϱ⠽¬¿î NG Æ©ºê°¡ °³¹ßµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ¿¬±¸°³¹ß¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÅõÀÚ·Î ±â´É¼ºÀ» °­È­ÇÑ Â÷¼¼´ë NG Æ©ºêÀÇ µµÀÔÀÌ ¿¹»óµÇ¸ç, ÇâÈÄ ¼ö³â°£ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

ºÎ¹®

ȯÀÚ À¯Çü(¼ºÀΠȯÀÚ, ¼Ò¾Æ ȯÀÚ, ³ëÀΠȯÀÚ), ÀûÀÀÁõ À¯Çü(À§¾Ï, ½Äµµ¾Ï, IBD, ¸¸¼º ½ÅÀ庴, ¿¬Çϰï¶õ, ±âŸ ÀûÀÀÁõ À¯Çü), Æ©ºê À¯Çü(¼Ò±¸°æ Çǵù Æ©ºê, ´ë±¸°æ Çǵù Æ©ºê), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø¡¤¿ä¾ç½Ã¼³ ÃÖÁ¾»ç¿ëÀÚ, ÀçÅà °£º´ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Nasogastric Tubes Market to Reach US$700.1 Million by 2030

The global market for Nasogastric Tubes estimated at US$543.4 Million in the year 2024, is expected to reach US$700.1 Million by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Adult Patients, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$399.9 Million by the end of the analysis period. Growth in the Pediatric Patients segment is estimated at 3.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$148.0 Million While China is Forecast to Grow at 8.0% CAGR

The Nasogastric Tubes market in the U.S. is estimated at US$148.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$144.6 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Nasogastric Tube Market - Key Trends & Drivers Summarized

How Is the Nasogastric Tube Market Evolving to Meet Medical and Nutritional Needs?

The nasogastric (NG) tube market has undergone significant advancements, with improvements in materials, design, and application techniques that enhance patient comfort and treatment efficiency. NG tubes are widely used for enteral feeding, medication administration, and gastric decompression, serving as a critical tool in hospitals, home care settings, and intensive care units (ICUs). Traditional PVC-based tubes have been gradually replaced by softer, biocompatible materials such as silicone and polyurethane, which offer greater flexibility and reduce the risk of mucosal injury. Additionally, the development of anti-clogging and antimicrobial-coated NG tubes has improved patient outcomes by minimizing infections and obstructions. The increasing prevalence of dysphagia, neurological disorders, and gastrointestinal diseases has further driven the demand for nasogastric tubes, particularly in aging populations and critical care patients. The expansion of home healthcare services has also fueled the need for long-term enteral feeding solutions, making NG tubes an essential component in chronic disease management.

Why Is the Demand for Nasogastric Tubes Rising Across Various Healthcare Segments?

The increasing incidence of conditions that require enteral feeding, such as stroke, cancer, and neurological disorders, has led to a significant rise in the use of NG tubes. Hospitals and healthcare facilities rely on these devices for short-term feeding in critically ill patients, while long-term care facilities and home healthcare providers utilize them for sustained nutritional support. The growing prevalence of head and neck cancers, which often lead to swallowing difficulties, has further contributed to market expansion. Additionally, NG tubes play a vital role in emergency and trauma care, where they are used for gastric decompression and aspiration of ingested toxins. The pediatric and neonatal care segments have also witnessed increased demand for NG tubes, as premature infants and infants with congenital abnormalities often require specialized feeding solutions. Furthermore, the rise in surgical procedures requiring post-operative nutritional management has strengthened the market for NG tubes, particularly in gastrointestinal and bariatric surgeries.

How Are Technological Innovations and Regulatory Developments Shaping the Market?

The nasogastric tube industry has seen several innovations aimed at improving safety, reducing complications, and enhancing patient comfort. The introduction of radiopaque and color-coded NG tubes has improved placement verification and reduced misplacement risks, which are critical concerns in NG tube usage. The development of pH-sensitive indicators and electromagnetic placement verification systems has further enhanced tube positioning accuracy, reducing the reliance on X-ray confirmations and minimizing exposure to radiation. Additionally, antimicrobial coatings and hydrogel-based NG tubes are gaining popularity due to their ability to reduce bacterial colonization and prevent infections. Regulatory agencies such as the FDA and European Medicines Agency (EMA) are implementing stricter guidelines to ensure the safety and efficacy of NG tubes, prompting manufacturers to invest in high-quality and standardized products. As healthcare facilities increasingly prioritize infection control and patient safety, the demand for advanced NG tube solutions is expected to grow.

What Are the Key Growth Drivers Boosting the Nasogastric Tube Market?

The growth in the nasogastric tube market is driven by several factors, including the rising prevalence of dysphagia and gastrointestinal disorders, increasing demand for enteral feeding solutions, and advancements in tube placement technologies. One of the primary drivers is the aging population, which has a higher incidence of conditions requiring long-term enteral nutrition. The growing adoption of home healthcare services has also played a crucial role, as more patients receive enteral feeding outside hospital settings. Additionally, the expansion of ICU facilities and critical care units, particularly in response to global health crises, has fueled demand for NG tubes in emergency and intensive care scenarios. The increasing focus on minimally invasive medical procedures has led to the development of user-friendly NG tubes with improved safety features, reducing complications and enhancing patient experience. Moreover, the continued investment in medical research and development is expected to introduce next-generation NG tubes with enhanced functionality, further propelling market growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Nasogastric Tubes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Patient Type (Adult Patients, Pediatric Patients, Geriatric Patients); Indication Type (Stomach Cancer, Esophageal Cancer, IBD, Chronic Kidney Disease, Dysphagia, Other Indication Types); Tube Type (Small-Bore Feeding Tubes, Large-Bore Feeding Tubes); End-Use (Hospitals & Nursing Homes End-Use, Home Care End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â